Lixte Biotechnology announces publication of preclinical data in EMBO Reports
PremiumThe FlyLixte Biotechnology announces publication of preclinical data in EMBO Reports
5M ago
Lixte Biotechnology Appoints New Chief Medical Officer
Premium
Company Announcements
Lixte Biotechnology Appoints New Chief Medical Officer
5M ago
Lixte Biotechnology appoints Jan Schellens as CMO
Premium
The Fly
Lixte Biotechnology appoints Jan Schellens as CMO
5M ago
Lixte Biotechnology provides update on progress with LB-100
PremiumThe FlyLixte Biotechnology provides update on progress with LB-100
8M ago
Lixte Biotechnology announces presentation of LB-100
Premium
The Fly
Lixte Biotechnology announces presentation of LB-100
9M ago
Lixte Biotechnology enters patent license agreement with NINDS, NCI
Premium
The Fly
Lixte Biotechnology enters patent license agreement with NINDS, NCI
9M ago
Lixte Biotechnology appoints Bas van der Baan as President, CEO
PremiumThe FlyLixte Biotechnology appoints Bas van der Baan as President, CEO
1y ago
Lixte Biotechnology announces supported collaborative trial to study LB-100
Premium
The Fly
Lixte Biotechnology announces supported collaborative trial to study LB-100
1y ago
Lixte Biotechnology files to sell 583,334 shares of common stock for holders
Premium
The Fly
Lixte Biotechnology files to sell 583,334 shares of common stock for holders
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100